Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.
Journal: Cancer
Published: September 10, 2025
Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study.
Journal: The oncologist
Published: September 05, 2025
Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies.
Journal: Journal for immunotherapy of cancer
Published: May 29, 2025
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.
Journal: The oncologist
Published: November 17, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 01, 2024
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction.
Journal: The oncologist
Published: June 28, 2024
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer.
Journal: American journal of clinical oncology
Published: April 19, 2021
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2021
Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.
Journal: Immunity
Published: July 31, 2020
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.
Journal: Future oncology (London, England)
Published: September 13, 2019
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
Journal: Theranostics
Published: March 31, 2017
Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Journal: Journal of hematology & oncology
Published: March 22, 2017
Last Updated: 09/26/2026